跳转至内容
Merck
CN

S5814

TMB底物终止液

chromogenic, powder

别名:

TMB liquid substrate system stop reagent

登录 查看组织和合同定价。

选择尺寸


关于此项目

UNSPSC Code:
12352204
NACRES:
NA.83
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

TMB底物终止液, powder, ELISA, 450 nm

form

powder

storage temp.

room temp

Quality Level

Application

TMB 底物终止(STOP)试剂可用于:
  • 体外 制备和分析中性粒细胞胞外诱捕网(NET)
  • 直接结合酶联免疫吸附测定(ELISA)
  • 干扰测定

General description

TMB 底物终止(STOP)试剂用于终止 ELISA 中的TMB底物反应,将吸光度从蓝色(620 nm)改为黄色(450 nm)。

pictograms

CorrosionExclamation mark

signalword

Danger

Hazard Classifications

Acute Tox. 4 Dermal - Acute Tox. 4 Oral - Eye Dam. 1 - Skin Corr. 1 - Skin Sens. 1 - STOT SE 3

target_organs

Respiratory system

存储类别

8A - Combustible corrosive hazardous materials

wgk

WGK 3

flash_point_f

260.6 °F - closed cup

flash_point_c

127 °C - closed cup

法规信息

新产品
此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Fresthel Monica M Climacosa et al.
Protein and peptide letters, 27(10), 962-970 (2020-04-29)
Microbe-Binding Peptides (MBPs) are currently being investigated to address the problem of antimicrobial resistance. Strategies enhancing their antimicrobial activity have been developed, including peptide dimerization. Here, we present an alternative approach based on peptide polymerization, yielding hapten-labelled polymeric MBPs that
Julian C Dunkley et al.
American journal of physiology. Heart and circulatory physiology, 320(5), H1862-H1872 (2021-03-27)
There are currently no Food and Drug Administration-approved treatments for heart failure with preserved ejection fraction (HFpEF). Here we compared the effects of exercise with and without α/β-adrenergic blockade with carvedilol in Col4a3-/- Alport mice, a model of the phenogroup
Development of a reliable assay to measure glypican-1 in plasma and serum reveals circulating glypican-1 as a novel prostate cancer biomarker
Levin RA, et al.
Oncotarget, 9(32), 22359-22359 (2018)
Marília Santini-Oliveira et al.
Vaccines, 10(10) (2022-10-28)
We report the successful closure of Phase I clinical trials, comprising Phases Ia and Ib, of the vaccine candidate against human schistosomiasis: the Schistosoma mansoni 14 kDa fatty acid-binding protein (Sm14) + glucopyranosyl lipid A in squalene emulsion (GLA-SE). Shown
Prevalence of interfering antibodies in dogs and cats evaluated using a species-independent assay
Bergman D, et al.
Veterinary Clinical Pathology / American Society For Veterinary Clinical Pathology, 47(2), 205-212 (2018)

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持